ApoB test — research review 1

...so ApoB, or apolipoprotein B, is essentially a measurement of the total number of atherogenic particles in your bloodstream.

And why is that important for longevity? We hear a lot about cholesterol, but ApoB is a bit different.

Exactly. While cholesterol tests measure the amount of cholesterol in different lipoproteins, ApoB quantifies the number of particles that actually carry that cholesterol and can contribute to plaque buildup. Each of these problematic particles, like LDL, VLDL, and Lp(a), carries exactly one ApoB molecule.

So, it’s a more direct count of the ‘bad actors’, rather than just the cholesterol they contain.

Precisely. A higher ApoB count indicates a greater number of these particles, and a higher risk of them getting into the artery wall and kickstarting atherosclerosis. Research in journals like JAMA in 2020 has shown a strong correlation between elevated ApoB and cardiovascular disease risk.

And cardiovascular disease is, of course, a major factor in healthy longevity. What about its use as a direct longevity biomarker, like for biological age?

That's where things get a bit more nuanced. While ApoB is clearly a critical cardiovascular risk factor, and managing that risk improves healthspan, its role as a direct predictor or component of biological age, independent of its atherosclerosis implications, is still an area of active research. We don't yet have definitive evidence that ApoB itself is a measure of biological age in the same way some epigenetic clocks are.

So, it’s a powerful tool for assessing a crucial longevity risk factor, but not necessarily a direct measure of aging processes yet.

Exactly. It's a key piece of the puzzle, informing strategies to mitigate cardiovascular risk, which is fundamental to extending healthy lifespan.